
Last 4 earnings calls · through Q2 FY2026
The bull case is that demand has finally turned, with China and emerging markets growing again and customers no longer postponing equipment decisions.
Mettler-Toledo keeps launching new instruments that customers pay a premium for, so it has been able to raise prices every year even while volumes were weak.
Service on a large installed base is growing faster than instrument sales and adds recurring revenue that softens the effect of slower equipment orders.
Management has lifted its full-year sales and profit outlook as conditions improved, and a long run of beating estimates supports the case that the plan is cautious.
The bear case is that customers have repeatedly delayed capital spending, so each recovery forecast has slipped and growth keeps resting on price rather than units sold.
Planned U.S. manufacturing and onshoring investment is real but construction takes years, and management keeps pushing the revenue benefit further out into later years.
Tariffs, tariff refunds and currency moves keep distorting reported sales and margins, making it hard to tell how much improvement comes from the underlying business.
Product inspection and food retail depend on a handful of large projects, so growth swings sharply from quarter to quarter regardless of underlying demand.
In short: The growth outlook has improved, but volume still depends on customers releasing projects they have delayed.
China is about one-sixth of sales; a year ago management called its first industrial growth in two years tentative, and it now guides the full year to high single digit.
Management lifted its local currency sales and profit growth guidance, and has now beaten consensus earnings estimates in each of the last eight quarters.
In late 2025 management expected a benefit in 2026 and more in 2027; it now describes the work as early innings and points to 2027 and 2028 for the larger investment.
Price realization is approaching 3% for the full year, so very little of the organic growth target depends on customers actually buying more instruments.
In short: Margins are expanding, but currency and one-time tariff refunds blur reported figures.
Gross margin reached 63.3% in the second quarter, helped by price, lower tariff rates and productivity, showing the company can protect profitability in a tariffed environment.
Diluted shares are down 9% over three years and repurchases are guided higher this year, so per-share profit compounds faster than total company profit.
Reported results included a one-time refund that management excluded from its adjusted figures, so the headline growth rate overstates the earnings run rate going forward.
Operating margin is guided up 60 to 70 basis points excluding currency but only 10 to 20 basis points as reported, so Swiss franc and euro moves decide what the reported numbers show.
In short: Pricing power and the service base are strengths; tariffs and end-market concentration are the main risks.
Price realization rose to around 3% in the second quarter, reflecting customers paying for measurement accuracy, compliance and workflow software.
Service passed $1 billion in sales while management sizes the serviceable installed base at roughly $3 billion, leaving room for service to keep growing faster than instruments.
Tariffs added about $50 million of cost in 2025 and guidance assumes rates return to prior levels later this year, so the current relief may not hold.
About 60% of core industrial sales go to pharma, food manufacturing and chemical, and revenue fell 12.4% in the last deep downturn even though operating margin held.